Securities Claims Against Drug Maker, CEO Survive Dismissal Bid

Mealey's (March 12, 2021, 12:48 PM EST) -- BROOKLYN, N.Y. — A federal judge in New York on March 10 partially granted a motion to dismiss in a securities class action lawsuit against a biopharmaceutical company and certain of...
To view the full article, register now.